Edition:
United States

Profile: IntriCon Corp (IIN.A)

IIN.A on American Stock Exchange

17.41USD
23 Aug 2019
Change (% chg)

$-0.17 (-0.97%)
Prev Close
$17.58
Open
$17.41
Day's High
$17.41
Day's Low
$17.41
Volume
100
Avg. Vol
387
52-wk High
$76.00
52-wk Low
$16.88

IntriCon Corporation, incorporated on June 24, 1930, is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market. The Company has facilities in Minnesota, California, Singapore, Indonesia, the United Kingdom and Germany, and operates through its subsidiaries. The Company's product offering includes a hearing aid discount program for health plans. This program is available around the nation to health insurers, including employer-sponsored, individual and Medicare plans. The Company also has various international value hearing aid (VHA) initiatives. In the medical bio-telemetry market, the Company is focused on sales of bio-telemetry devices for life-critical diagnostic monitoring. Using its nanoDSP and BodyNet technology platforms, the Company manufactures microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components and bio-telemetry devices for medical device manufacturers.

The Company offers medical manufacturers the capabilities to design, develop, manufacture and distribute medical devices. The Company has a strategic relationship with Advanced Medical Electronics Corp. (AME) that allows it to develop bio-telemetry devices that connect patients and care givers, providing critical information and feedback. Through its nanoDSP technology, it offers a range of ultra-low-power digital signal processing (ULP DSP) amplifiers for hearing, medical and professional audio applications. Its nanoDSP incorporates ultra-miniature hardware with signal processing algorithms to produce devices that are smaller. The Company's DSP portfolio also includes its Reliant CLEAR feedback canceller. Additionally, its DSP technologies are utilized in its Audion8 and Audion16, its eight-channel hearing aid amplifier and dynamic range compression 16-channel hearing aid amplifiers. In addition to multiple compression channels, the amplifier has a set of adaptive features.

The Company's BodyNet ULP technology, including the nanoLink and PhysioLink wireless systems, offers solutions for transmitting the body's activities to caregivers and wireless audio links for professional communications and surveillance products. Potential BodyNet applications include electrocardiogram (ECG) diagnostics and monitoring, diabetes monitoring, sleep apnea studies and audio streaming for hearing devices. This system is based on over 2.4 gigahertz digital radio protocol in the industrial-scientific-medical (ISM) frequency band and enables audio and data streaming to ear-worn and body-worn applications over distances of over five meters. Included in its transducer line are its miniature medical coils and micro coils used in pacemaker programming and interventional catheter positioning applications.

For diabetes, the Company has partnered with Medtronic to manufacture wireless continuous glucose monitors, sensors and related accessories that measure glucose levels and deliver real-time blood glucose trend information. It also manufactures various accessories associated with Medtronic's CGM system, including MiniMed Connect, which links the MiniMed pump and CGM to certain smart devices providing users with a view of their blood sugar information. In addition to the MiniMed 530G system, the products the Company manufactures also support Medtronic's international insulin pump system offerings, such as the MiniMed 640G system. In the cardiac diagnostic monitoring market, the Company provides solutions for ambulatory cardiac monitoring. Its two product platforms include Sirona and Centauri. The Sirona platform, which incorporates the PhysioLink technology, is over two products in approximately one design: it can be used as an event recorder, a holter monitor or both. This platform is rechargeable and water spray proof.

The Company has a suite of medical coils and micro coils that it offers to various original equipment manufacturing (OEM) customers. These products are used in pacemaker programming and interventional catheter positioning applications. It manufactures bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system, as well as a family of safety needle products for an OEM customer that utilizes its insert and straight molding capabilities. These products are assembled using full automation, including built-in quality checks within the production lines. The Company offers a line of miniature, professional audio headset products used by customers focusing on emergency response needs. Its line includes a range of communication devices that are portable and perform in noisy or hazardous environments. These products are suited for applications in the fire, law enforcement, safety, aviation and military markets. In addition, the Company has a line of miniature ear- and head-worn devices used by performers and support staff in the music and stage performance markets.

Company Address

IntriCon Corp

1260 Red Fox Road
ARDEN HILLS   MN   55112
P: +1651.6369770
F: +1651.6369503

Company Web Links